187 related articles for article (PubMed ID: 9213214)
1. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
Cremers B; Flesch M; Südkamp M; Böhm M
J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
[TBL] [Abstract][Full Text] [Related]
2. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
Sarsero D; Fujiwara T; Molenaar P; Angus JA
Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
[TBL] [Abstract][Full Text] [Related]
3. Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue.
Schwinger RH; Böhm M; Erdmann E
J Cardiovasc Pharmacol; 1990 Jun; 15(6):892-9. PubMed ID: 1694911
[TBL] [Abstract][Full Text] [Related]
4. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
Muller CA; Opie LH; McCarthy J; Hofmann D; Pineda CA; Peisach M
J Am Coll Cardiol; 1998 Jul; 32(1):268-74. PubMed ID: 9669280
[TBL] [Abstract][Full Text] [Related]
5. Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.
Schwinger RH; Böhm M; Erdmann E
Klin Wochenschr; 1990 Aug; 68(16):797-805. PubMed ID: 2145465
[TBL] [Abstract][Full Text] [Related]
6. The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts.
Clozel JP; Véniant M; Osterrieder W
Cardiovasc Drugs Ther; 1990 Jun; 4(3):731-6. PubMed ID: 1963792
[TBL] [Abstract][Full Text] [Related]
7. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.
Brixius K; Mohr V; Müller-Ehmsen J; Hoischen S; Münch G; Schwinger RH
Br J Pharmacol; 1998 Sep; 125(1):41-8. PubMed ID: 9776342
[TBL] [Abstract][Full Text] [Related]
8. Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy.
Fang LM; Osterrieder W
Eur J Pharmacol; 1991 Apr; 196(2):205-7. PubMed ID: 1651875
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
Noll G; Lüscher TF
Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
[TBL] [Abstract][Full Text] [Related]
10. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
Hoischen S; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Min JY; Sandmann S; Meissner A; Unger T; Simon R
J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
[TBL] [Abstract][Full Text] [Related]
12. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Billman GE; Hamlin RL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
[TBL] [Abstract][Full Text] [Related]
13. Relative selectivity for negative chronotropic and inotropic effects of a novel dihydropyridine derivative CD-832.
Noguchi K; Masumiya H; Sasaki T; Takahashi K; Araki H; Higuchi S; Tanaka H; Shigenobu K
Eur J Pharmacol; 1996 Jul; 308(1):53-9. PubMed ID: 8836632
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
Orito K; Satoh K; Taira N
J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action.
Osterrieder W; Holck M
J Cardiovasc Pharmacol; 1989 May; 13(5):754-9. PubMed ID: 2472524
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
Véniant M; Clozel JP; Hess P; Wolfgang R
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S55-8. PubMed ID: 1725005
[TBL] [Abstract][Full Text] [Related]
17. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
Schwinger RH; Böhm M; Erdmann E
Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
[TBL] [Abstract][Full Text] [Related]
18. The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.
Hugtenburg JG; Mathy MJ; Beckeringh JJ; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):558-66. PubMed ID: 2615847
[TBL] [Abstract][Full Text] [Related]
19. Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations.
Hugtenburg JG; Mathy MJ; Boddeke HW; Beckeringh JJ; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):567-75. PubMed ID: 2615848
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
Robertson MJ; Lumley P
Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]